Back

Interleukin-10 knockout mice do not reliably exhibit macroscopic inflammation: a natural history endoscopic surveillance study

Kim, S. Y.; Park, J.; Leite, G.; Pimentel, M.; Rezaie, A.

2021-12-21 immunology
10.1101/2021.12.18.472865 bioRxiv
Show abstract

BackgroundInterleukin (IL)-10 knockout (KO) mice, used as a model for inflammatory bowel disease (IBD), develop chronic enterocolitis. Endoscopy, the gold standard for evaluation of human mucosal health, is not widely available for murine models. We aimed to assess the natural history of left-sided colitis in IL-10 KO mice via serial endoscopies. MethodsBALB/cJ IL10 KO mice underwent regular endoscopic assessments from 2 up to 8 months of age. Procedures were recorded and blindly evaluated using a 4-component endoscopic score: mucosal wall transparency, intestinal bleeding, focal lesions and perianal lesions (0-3 points each). An endoscopic score [≥]1 point was considered as the presence of colitis/flare. ResultsIL-10 KO mice (N=40, 9 female) were assessed. Mean age at first endoscopy was 62.5{+/-}2.5 days; average number of procedures per mouse was 6.0{+/-}1.3. A total of 238 endoscopies were conducted every 24.8{+/-}8.3 days, corresponding to 124.1{+/-}45.2 days of surveillance per mouse (13.6 years cumulative surveillance). Thirty-three endoscopies in 24 mice (60%) detected colitis, mean endoscopy score 2.5{+/-}1.3 (range: 1-6.3). Nineteen mice (47.5%) had one episode of colitis and 5 (12.5%) had 2-3 episodes. All exhibited complete spontaneous healing on subsequent endoscopies. ConclusionsIn this largest endoscopic surveillance study of IL-10 KO mice, 40% of mice did not develop endoscopic left-sided colitis. Furthermore, IL-10 KO mice did not exhibit persistent colitis and universally exhibited complete spontaneous healing without treatment. The natural history of colitis in IL-10 KO mice may not be comparable with that of IBD in humans and requires careful consideration.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Inflammatory Bowel Diseases
16 papers in training set
Top 0.1%
34.5%
2
PLOS ONE
5266 papers in training set
Top 5%
27.7%
50% of probability mass above
3
Frontiers in Immunology
638 papers in training set
Top 2%
5.7%
4
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 0.3%
3.7%
5
Gut
40 papers in training set
Top 0.3%
3.4%
6
Scientific Reports
3612 papers in training set
Top 37%
2.9%
7
Frontiers in Pediatrics
32 papers in training set
Top 0.4%
2.2%
8
eLife
5828 papers in training set
Top 62%
1.0%
9
Gastroenterology
42 papers in training set
Top 0.9%
1.0%
10
International Journal of Molecular Sciences
494 papers in training set
Top 16%
0.6%
11
Journal of Allergy and Clinical Immunology
27 papers in training set
Top 0.6%
0.6%
12
mSphere
302 papers in training set
Top 7%
0.6%
13
JCI Insight
277 papers in training set
Top 8%
0.6%
14
European Journal of Immunology
60 papers in training set
Top 1%
0.6%
15
American Journal of Gastroenterology
17 papers in training set
Top 0.4%
0.6%
16
Open Forum Infectious Diseases
142 papers in training set
Top 3%
0.5%
17
Infection and Immunity
120 papers in training set
Top 2%
0.5%
18
Journal of Clinical Medicine
97 papers in training set
Top 6%
0.5%
19
The Journal of Immunology
166 papers in training set
Top 3%
0.5%
20
Microbiology Spectrum
469 papers in training set
Top 11%
0.5%
21
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.9%
0.5%